Dr Carolyn Wu, MD | |
300 Longwood Ave, Boston, MA 02115-5724 | |
(617) 355-6401 | |
(617) 730-0392 |
Full Name | Dr Carolyn Wu |
---|---|
Gender | Female |
Speciality | Ophthalmology |
Experience | 25 Years |
Location | 300 Longwood Ave, Boston, Massachusetts |
Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073603072 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207WX0110X | Ophthalmology - Pediatric Ophthalmology And Strabismus Specialist | 217221 (Massachusetts) | Secondary |
207W00000X | Ophthalmology | 217221 (Massachusetts) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Childrens Hospital Ophthalmology Foundation Inc | 8729049150 | 20 |
News Archive
Bristol-Myers Squibb Company and Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) approved ELIQUIS (apixaban) to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.
The enzyme that 'loads up' fat-carrying particles in the liver before they are transported around the body has been identified for the first time by scientists at the University of Warwick.
A method for controlling bacterial activity without antibiotics by interfering with their communication process has been developed by a young Hebrew University of Jerusalem researcher.
National Health Investors, Inc. announced today a $15.3 million acquisition of The Inn at Halcyon Village in Marysville, Ohio.
› Verified 4 days ago
Entity Name | Childrens Hospital Ophthalmology Foundation Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1770679045 PECOS PAC ID: 8729049150 Enrollment ID: O20041020000189 |
News Archive
Bristol-Myers Squibb Company and Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) approved ELIQUIS (apixaban) to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.
The enzyme that 'loads up' fat-carrying particles in the liver before they are transported around the body has been identified for the first time by scientists at the University of Warwick.
A method for controlling bacterial activity without antibiotics by interfering with their communication process has been developed by a young Hebrew University of Jerusalem researcher.
National Health Investors, Inc. announced today a $15.3 million acquisition of The Inn at Halcyon Village in Marysville, Ohio.
› Verified 4 days ago
Entity Name | Brigham And Women's Physicians Organization Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033535497 PECOS PAC ID: 3870405988 Enrollment ID: O20150107001260 |
News Archive
Bristol-Myers Squibb Company and Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) approved ELIQUIS (apixaban) to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.
The enzyme that 'loads up' fat-carrying particles in the liver before they are transported around the body has been identified for the first time by scientists at the University of Warwick.
A method for controlling bacterial activity without antibiotics by interfering with their communication process has been developed by a young Hebrew University of Jerusalem researcher.
National Health Investors, Inc. announced today a $15.3 million acquisition of The Inn at Halcyon Village in Marysville, Ohio.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Carolyn Wu, MD 300 Longwood Ave, Boston, MA 02115-5724 Ph: (617) 355-6401 | Dr Carolyn Wu, MD 300 Longwood Ave, Boston, MA 02115-5724 Ph: (617) 355-6401 |
News Archive
Bristol-Myers Squibb Company and Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) approved ELIQUIS (apixaban) to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.
The enzyme that 'loads up' fat-carrying particles in the liver before they are transported around the body has been identified for the first time by scientists at the University of Warwick.
A method for controlling bacterial activity without antibiotics by interfering with their communication process has been developed by a young Hebrew University of Jerusalem researcher.
National Health Investors, Inc. announced today a $15.3 million acquisition of The Inn at Halcyon Village in Marysville, Ohio.
› Verified 4 days ago
Dr. Maan Sulaiman A Alkharashi, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 300 Longwood Ave, Fegan 4, Boston, MA 02115 Phone: 857-523-6040 | |
Daniel J Townsend, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 175 Cambridge St, C/o Prooptical, Boston, MA 02114 Phone: 617-723-3937 Fax: 617-523-5006 | |
Daniel Robert Lefebvre, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, 10th Floor -- Ophthalmic Plastic Surgery, Boston, MA 02114 Phone: 617-523-7900 | |
Dr. Seanna Rae Grob, MD, MAS Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-523-7900 | |
Ravi Parikh, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-573-3288 | |
Michael V Boland, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-573-3611 | |
Dr. Parvathy A Pillai, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-647-1226 Fax: 617-573-3181 |